BRIEF published on 05/28/2024 at 19:05, 10 months 9 days ago JTC Team to Host the Virtual Investor Pitch Conference on June 17-18, 2024 Investor Relations Webcast Live Q&A Virtual Investor Conference Corporate Communications
PRESS RELEASE published on 05/28/2024 at 19:00, 10 months 9 days ago JTC Team to Host the Virtual Investor Pitch Conference on June 17-18, 2024 JTC Team announces Virtual Investor Pitch Conference on June 17-18, 2024, featuring live video webcast presentations with Q&A. Participating company line-up to be revealed later Investor Relations JTC Team Virtual Investor Pitch Conference Live Video Webcast Q&A
BRIEF published on 05/23/2024 at 16:35, 10 months 14 days ago GRI Bio (NASDAQ: GRI) Participates in Virtual Investor CEO Connect Investor Relations Corporate Communications GRI Bio Virtual Investor CEO Connect
PRESS RELEASE published on 05/23/2024 at 16:30, 10 months 14 days ago GRI Bio (NASDAQ: GRI) Participates in Virtual Investor CEO Connect JTC Team announces CEO Connect segment with GRI Bio's Marc Hertz, PhD, covering recent achievements and upcoming milestones. Virtual Investor platform offers more videos GRI Bio Virtual Investor CEO Connect JTC Team Communication Strategies
BRIEF published on 04/25/2024 at 15:50, 11 months 11 days ago Moleculin Biotech Emphasizes Annamycin's Role in AML Treatment in JTC Virtual Investor Segment Clinical Trials Investment Opportunity Moleculin Biotech Annamycin AML Treatment
PRESS RELEASE published on 04/25/2024 at 15:45, 11 months 11 days ago Moleculin Biotech (NASDAQ:MBRX) Participates in Virtual Investor "What This Means" Segment Hosted by JTC Team Moleculin CEO highlights Annamycin's differentiation in AML treatment landscape and investment opportunity. Positive interim data shared in 'What This Means' segment Investment Opportunity Clinical Trial Moleculin Biotech Annamycin AML Treatment
PRESS RELEASE published on 10/18/2023 at 16:00, 1 year 5 months ago JTC Team Announces Presenting Company Line Up for the Virtual Investor “Ask the CEO” Conference Being Held October 24-25, 2023
Published on 04/07/2025 at 13:30, 32 minutes ago Orogen Royalties Announces Mineral Resource and Reserve Update on Producing Ermitaño Royalty Including Initial Inferred Resource for the Navidad Vein
Published on 04/07/2025 at 13:00, 1 hour 2 minutes ago Moderna to Showcase Extensive Infectious Disease Research at ESCMID 2025
Published on 04/07/2025 at 13:00, 1 hour 2 minutes ago Electric Metals' Long-standing, Integrated Domestic Manganese Strategy Validated by U.S. Policy Shift Aimed at Restoring American Industrial Independence
Published on 04/07/2025 at 13:00, 1 hour 2 minutes ago EON Resources Inc. Confirms Oil Sales Hedged at $70.00 per Barrel for the Rest of CY 2025
Published on 04/07/2025 at 12:30, 1 hour 32 minutes ago iFabric Corp Acquires Remaining 25% Stake in Markham Property and Signs New Banking Agreement
Published on 04/07/2025 at 13:00, 1 hour 2 minutes ago CureVac Receives U.S. FDA IND Clearance to Initiate Phase 1 Clinical Trial for Novel mRNA-Based Precision Immunotherapy in Squamous Non-Small Cell Lung Cancer
Published on 04/07/2025 at 12:57, 1 hour 5 minutes ago PFISTERER acquires long-standing partner Power CSL - portfolio expanded to include subsea solutions
Published on 04/07/2025 at 11:57, 2 hours 4 minutes ago Share buyback: Announcement pursuant to Article 5 (1) (b) and (3) of Regulation (EU) No. 596/2014
Published on 04/07/2025 at 11:44, 2 hours 17 minutes ago EQS-Adhoc: Rubean AG: Change in the Supervisory Board
Published on 04/07/2025 at 10:30, 3 hours 31 minutes ago Original-Research: UmweltBank AG (von GBC AG): Buy
Published on 04/07/2025 at 07:01, 7 hours 1 minute ago bioMérieux obtains CE-marking for LUMED™ APSS™, a cutting-edge software solution to aid medical decision-making in Antimicrobial Stewardship
Published on 04/04/2025 at 19:18, 2 days 18 hours ago Mersen: Number of shares and voting rights as of March 31, 2025
Published on 04/04/2025 at 18:17, 2 days 19 hours ago Reporting on share buyback transactions carried out between March 31 and April 3, 2025
Published on 04/04/2025 at 18:13, 2 days 19 hours ago Total number of voting rights and shares making up the share capital at March 31, 2025
